Haruo Iwabuchi

Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs.

Kenji Kawai, Y Kawasaki-Tokui, Tomoyo ODAKA et al. · PubMed · 1997 · 99 citations

Pharmacotherapy, Experimental Pharmacology, Insulin Signaling +16

Formation of a Novel Quinone Epoxide Metabolite of Troglitazone with Cytotoxic to HepG2 Cells

Yui Yamamoto, Hiroshi Yamazaki, Tomoko Ikeda et al. · Drug Metabolism and Disposition · 2002 · 82 citations

Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-?-d-ARABINO-Pentofuranosyl) cytosine) and itsN4-palmitoyl derivative (CS-682)

Kenji Hanaoka, Masako Suzuki, Tomowo Kobayashi et al. · International Journal of Cancer · 1999 · 59 citations · Full text

Inhibition of In Vitro Metabolism of Simvastatin by Itraconazole in Humans and Prediction of In Vivo Drug-Drug Interactions

Michi Ishigam, Minoru Uchiyama, Tomoko Kondo et al. · Pharmaceutical Research · 2001 · 58 citations

Ethylene Glycol Monomethyl Ether–Induced Toxicity Is Mediated through the Inhibition of Flavoprotein Dehydrogenase Enzyme Family

Makoto Takei, Wataru Saitoh, Tomoe Tanimoto et al. · Toxicological Sciences · 2010 · 45 citations · Full text

Metabolomic Profiling, Dehydrogenase Deficiency, Toxicological Mechanism +17